Sensing of Catecholamine in Human Urine Using a Simple Colorimetric Assay Based on Direct Melanochrome and Indolequinone Formation
- PMID: 37112313
- PMCID: PMC10146333
- DOI: 10.3390/s23083971
Sensing of Catecholamine in Human Urine Using a Simple Colorimetric Assay Based on Direct Melanochrome and Indolequinone Formation
Abstract
We used the first enzyme-free synthesis and stabilization of soluble melanochrome (MC) and 5,6-indolequinone (IQ) derived from levodopa (LD), dopamine (DA), and norepinephrine (NE) oxidation to develop a simple colorimetric assay for catecholamine detection in human urine, also elucidating the time-dependent formation and molecular weight of MC and IQ using UV-Vis spectroscopy and mass spectrometry. The quantitative detection of LD and DA was achieved in human urine using MC as a selective colorimetric reporter to demonstrate the potential assay applicability in a matrix of interest in therapeutic drug monitoring (TDM) and in clinical chemistry. The assay showed a linear dynamic range between 5.0 mg L-1 and 50.0 mg L-1, covering the concentration range of DA and LD found in urine samples from, e.g., Parkinson's patients undergoing LD-based pharmacological therapy. The data reproducibility in the real matrix was very good within this concentration range (RSDav% 3.7% and 6.1% for DA and LD, respectively), also showing very good analytical performances with the limits of detection of 3.69 ± 0.17 mg L-1 and 2.51 ± 0.08 mg L-1 for DA and LD, respectively, thus paving the way for the effective and non-invasive monitoring of dopamine and levodopa in urine from patients during TDM in Parkinson's disease.
Keywords: Parkinson’s disease; catecholamines oxidation; colorimetric assay; dopamine; indolequinone; levodopa; melanochrome; norepinephrine; therapeutic drug monitoring; urine analysis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Melanochrome-based colorimetric assay for quantitative detection of levodopa in co-presence of carbidopa and its application to relevant anti-Parkinson drugs.Anal Bioanal Chem. 2022 Feb;414(4):1713-1722. doi: 10.1007/s00216-021-03804-8. Epub 2021 Nov 29. Anal Bioanal Chem. 2022. PMID: 34842945
-
Machine-learning assisted multiplex detection of catecholamine neurotransmitters with a colorimetric sensor array.Anal Methods. 2023 Mar 2;15(9):1123-1134. doi: 10.1039/d2ay01797k. Anal Methods. 2023. PMID: 36756908
-
Determination of catecholamines by flow-injection analysis and high-performance liquid chromatography with chemiluminescence detection.J Pharm Biomed Anal. 2007 Apr 11;43(5):1673-81. doi: 10.1016/j.jpba.2006.12.021. Epub 2007 Jan 5. J Pharm Biomed Anal. 2007. PMID: 17289328
-
Protective and toxic roles of dopamine in Parkinson's disease.J Neurochem. 2014 Jun;129(6):898-915. doi: 10.1111/jnc.12686. Epub 2014 Mar 18. J Neurochem. 2014. PMID: 24548101 Review.
-
Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist.Curr Neuropharmacol. 2016;14(4):356-63. doi: 10.2174/1570159x14666151208114634. Curr Neuropharmacol. 2016. PMID: 26644151 Free PMC article. Review.
Cited by
-
Quantitative Colorimetric Sensing of Carbidopa in Anti-Parkinson Drugs Based on Selective Reaction with Indole-3-Carbaldehyde.Sensors (Basel). 2023 Nov 13;23(22):9142. doi: 10.3390/s23229142. Sensors (Basel). 2023. PMID: 38005530 Free PMC article.
-
Preparation of carbon quantum dot fluorescent probe from waste fruit peel and its use for the detection of dopamine.RSC Adv. 2024 Jan 8;14(3):1813-1821. doi: 10.1039/d3ra06799h. eCollection 2024 Jan 3. RSC Adv. 2024. PMID: 38192308 Free PMC article.
References
-
- Lettieri M., Emanuele R., Scarano S., Palladino P., Minunni M. Melanochrome-based colorimetric assay for quantitative detection of levodopa in co-presence of carbidopa and its application to relevant anti-Parkinson drugs. Anal. Bioanal. Chem. 2022;414:1713–1722. doi: 10.1007/s00216-021-03804-8. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials